000 | 01984 a2200553 4500 | ||
---|---|---|---|
005 | 20250516205426.0 | ||
264 | 0 | _c20150413 | |
008 | 201504s 0 0 eng d | ||
022 | _a1582-4934 | ||
024 | 7 |
_a10.1111/jcmm.12267 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Yucheng | |
245 | 0 | 0 |
_aInhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetes. _h[electronic resource] |
260 |
_bJournal of cellular and molecular medicine _cJun 2014 |
||
300 |
_a1203-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnthracenes _xpharmacology |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
650 | 0 | 4 |
_aAorta _xdrug effects |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCurcumin _xanalogs & derivatives |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
650 | 0 | 4 |
_aDiabetic Cardiomyopathies _xmetabolism |
650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMast Cells _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xgenetics |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
700 | 1 | _aWang, Yonggang | |
700 | 1 | _aMiao, Xiao | |
700 | 1 | _aZhou, Shanshan | |
700 | 1 | _aTan, Yi | |
700 | 1 | _aLiang, Guang | |
700 | 1 | _aZheng, Yang | |
700 | 1 | _aLiu, Quan | |
700 | 1 | _aSun, Jian | |
700 | 1 | _aCai, Lu | |
773 | 0 |
_tJournal of cellular and molecular medicine _gvol. 18 _gno. 6 _gp. 1203-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcmm.12267 _zAvailable from publisher's website |
999 |
_c23726132 _d23726132 |